ITMCTR2100004495招募中1 期
A randomized, controlled, multicentre clinical study of optimizing Yantiao prescription in the treatment of septic shock
Shuguang Hospital Affiliated to Shanghai University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1. Patients aged 18-80 years old;
- •2. Patients with septic shock;
- •3. Patients with acute attack within 3 days.
排除标准
- •1. Patients with allergic constitution or allergic to known components of the drug;
- •2. Mental patients;
- •3. Subjects with intestinal obstruction caused by other causes;
- •4. Patients with malignant tumor;
- •5. The subjects who did not meet the inclusion criteria, did not use drugs according to the regulations, could not determine the efficacy or incomplete information, which affected the efficacy or safety judgment.
研究者
相似试验
尚未招募
4 期
A randomized, controlled, multicentre clinical study of Shengu Capsule in the treatment of postmenopausal osteoporosis (deficiency syndrome of liver and kidney)Postmenopausal OsteoporosisITMCTR2100004996Fujian Academy of Chinese Medical Sciences
招募中
1 期
A randomized, controlled, multicenter clinical study of theimproved sitting Wuqinxiintervention for mechanically ventilated patients in the intensive care unitRespiratory failureITMCTR2000003360Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
招募中
Unknown
A randomized, controlled, multicenter clinical study of TCM Tuna Gong in the treatment of chronic lower extremity venous insufficiencyITMCTR2024000018Shuguang Hospital, Shanghai University of Traditional Chinese Medicine
招募中
不适用
A multi-center, randomized controlled clinical study for Xiansen Decoction combined with radiotherapy and chemotherapy in the treatment of locally advanced nasopharyngeal carcinomaITMCTR1900002641The First Affiliated Hospital of Guangzhou University of Chinese Medicine
进行中（未招募）
不适用
Study comparing the use of a medical procedure (endoscopic band ligation) versus a drug treatment (carvedilol) to prevent bleeding of esophageal varices in patients with liver disease.Esophageal variceal bleeding in patients with cirrhosisEUCTR2011-006208-11-ESCAIBER